Maize Lethal Necrosis (MLN) – What is happening in Africa BM Prasanna and WL Trevisan Infected maize fields in Bomet, Kenya (Sept Disease Symptoms What is Maize Lethal Necrosis (MLN)? MCMV Potyvirus SCMV MDMV WSMV MLN Individual infection with MCMV alone can cause serious disease (as seen in eastern Africa)! Severe symptoms and yield loss (Rift valley, 2013) Seed industry under stress in eastern Africa Responses of some commercial maize hybrids against MLN MLN in a Hybrid Seed Production Field in Tanzania Losses due to MLN along the maize value chain Food and economic security at household and national levels threatened Losses for seed producers (for both growers and seed companies) Millers (both in quality and quantity) Transporters (reduced volume of business) Storage facilities (dormant capacity) Middlemen (loss of business volumes) Why is MLN devastating in eastern Africa? New and perhaps highly virulent strains of MCMV and SCMV Conducive environment for survival and spread of insect vectors Continuous maize cropping in certain regions –> build-up of virus inoculum Widespread cultivation of susceptible germplasm that was never screened for MCMV Distribution of MCMV and SCMV in 15 counties in Kenya2013 100 90 80 70 60 50 40 30 20 10 0 MCMV ONLY SCMV ONLY Sample size 3000 MCMV + SCMV Source: Anne Wangai, KALRO MLN Screening Facility established by CIMMYT-KALRO at Naivasha, Kenya CIMMYT’s Rapid Response (several projects): Intensive screening of maize germplasm (since 2012) Wide array of maize germplasm screened against MLN under artificial inoculation in MLN hotspots during 2012-2014 Promising MLN tolerant inbred lines and pre-commercial maize hybrids identified (although <10% of total number of germplasm entries evaluated) Summary of CIMMYT maize germplasm screened against MLN under artificial inoculation (2012-2014) Screening Completed by 1st Screening Locations Entries Total Rows Nov 2012 Olerai and Naivasha 2636 5272 June 2013 Oleriai and Marula farms 6021 16042 June 2014 Naivasha 15,712 32,807 Total 24,369 54,121 * 2nd Screening * 3rd Screening ** * CIMMYT, WEMA, DTMA, KALRO ** CIMMYT MLN Screening facility (ALL) Identification of MLN tolerant maize germplasm CLRCY039 (resistant) CML395 (susceptible) CML505 (susceptible) CLRCY034 (resistant) CIMMYT Update on MLN Tolerant Maize Germplasm (May 2013) CIMMYT Update on MLN Tolerant Maize Germplasm (May 2014) MLN Phenotyping Service initiated by CIMMYT to Public and Private Sector Partners in Africa since 2013 S.No. Partner Institutions Total No. of Total No. Entries of Rows 1 WEMA/Monsanto 2000 4000 2 Monsanto, South 252 504 3 Pioneer 810 810 4 Western Seed, 1181 1861 5 EA Seed, Kenya 410 820 6 Seed Co, Kenya 540 540 7 NASECO, Uganda 156 156 8 Aminata, Tanzania 24 48 9 Zamseed, Zambia 221 487 5594 9226 Africa Kenya Total MLN Marker Discovery and Validation by CIMMYT Key Findings GWAS results from DTMA and IMAS AM panels • Multiple leads – need to validate • Favorable alleles from Mexico Lowland Tropical lines Three biparental populations evaluated against MLN during 2012-2014 • Chr 6 potyvirus resistance locus detected in CML444 x CML539 • Two large effect QTL identified on chr 3 from CML543 • One large effect QTL identified on chr 9 from CML494 Full-sib genomic prediction from 0.58 to 0.66 based on 5-fold cross-validation Understanding MLN Insect-vector Dynamics Survey and identification of vectors endemic to eastern Africa that are capable of transmitting MLN-causing viruses, especially MCMV and SCMV Aphids Determining patterns of insect-vector movement and MLN disease development under natural conditions. Understanding of the effects of novel seed treatment technologies on the biology of insect-vectors transmitting MLN-causing viruses, and virus transmission competence. A project being implemented by ICIPE since 2013 under CRP MAIZE to probe MLN insectvector dynamics in eastern Africa Thrips Leaf hoppers Regional organizations in Africa are now increasingly engaged on MLN ASARECA-organized Workshop on MLN (August 21-23, 2013) for developing a regional strategy. The workshop focused on: 1. reviewing the current efforts to address the disease and identify gaps 2. identifying priority areas that need to be addressed that can further be developed into a proposal 3. developing a strategy and action plan to address MLN in ECA CIMMYT’s MLN-free Maize Germplasm Exchange Strategy Three levels of phytosanitary regulation Strict adherence to MLN management protocol at ALL nurseries /seed production fields in MLN endemic countries + official field inspection process CIMMYT-internal testing for detection of MLN causing viruses + official seed testing requirements, for safe exchange of germplasm CIMMYT’s MLN Quarantine Sites at Zimbabwe (from 2015) for effective exchange of CIMMYT germplasm with partners in Southern Africa What we do not know yet • How much is the extent of MCMV resistance in maize germplasm? • What is the extent of MCMV/SCMV variability? • What is the extent of seed transmission contributing to introduction / spread of the disease? What are the possible factors influencing seed transmission of MCMV? • What are the alternative hosts (reservoirs) for MCMV/SCMV in Africa? • What is the role of MSV and other pathogens/stresses on MLN epidemic? • What is the role of insect-vectors (maize thrips, beetles, other insects/nematodes) on MLN outbreak? Thanks to… CIMMYT–Africa colleagues KALRO colleagues, NARS and seed company partners across Africa USDA/OSU and University of Minnesota (especially Peg Redinbaugh and Ben Lockhart) Donor agencies: Bill & Melinda Gates Foundation, Syngenta Foundation, USAID and CRP MAIZE